These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A protein phosphatase 1 gamma (PP1γ) of the human protozoan parasite Trichomonas vaginalis is involved in proliferation and cell attachment to the host cell. Muñoz C; Pérez M; Orrego PR; Osorio L; Gutiérrez B; Sagua H; Castillo JL; Martínez-Oyanedel J; Arroyo R; Meza-Cervantez P; da Silveira JF; Midlej V; Benchimol M; Cordero E; Morales P; Araya JE; González J Int J Parasitol; 2012 Jul; 42(8):715-27. PubMed ID: 22713760 [TBL] [Abstract][Full Text] [Related]
24. Trichomoniasis: evaluation to execution. Harp DF; Chowdhury I Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359 [TBL] [Abstract][Full Text] [Related]
26. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167 [TBL] [Abstract][Full Text] [Related]
27. Genetic Diversity of Trichomonas Vaginalis Clinical Isolates According to Restriction Fragment Length Polymorphism Analysis of the 60-kDa Proteinase Gene. Hernández H; Fraga J; Marcet R; Alba A; Figueredo M; Alfonso Y; Rojas L; Sarracent J Acta Parasitol; 2019 Jun; 64(2):300-307. PubMed ID: 31165993 [TBL] [Abstract][Full Text] [Related]
28. Deazapurine Nucleoside Analogues for the Treatment of Natto MJ; Hulpia F; Kalkman ER; Baillie S; Alhejeli A; Miyamoto Y; Eckmann L; Van Calenbergh S; de Koning HP ACS Infect Dis; 2021 Jun; 7(6):1752-1764. PubMed ID: 33974405 [TBL] [Abstract][Full Text] [Related]
29. Characterization of cyclin-dependent kinases and Cdc2/Cdc28 kinase subunits in Trichomonas vaginalis. Amador E; López-Pacheco K; Morales N; Coria R; López-Villaseñor I Parasitology; 2017 Apr; 144(5):571-582. PubMed ID: 27928981 [TBL] [Abstract][Full Text] [Related]
30. Membrane-shed vesicles from the parasite Trichomonas vaginalis: characterization and their association with cell interaction. Nievas YR; Coceres VM; Midlej V; de Souza W; Benchimol M; Pereira-Neves A; Vashisht AA; Wohlschlegel JA; Johnson PJ; de Miguel N Cell Mol Life Sci; 2018 Jun; 75(12):2211-2226. PubMed ID: 29222644 [TBL] [Abstract][Full Text] [Related]
31. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors. Petmitr PC; Ramdja M; Kajorndechakiat S Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077 [TBL] [Abstract][Full Text] [Related]
32. Rai AK; Johnson PJ Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21354-21360. PubMed ID: 31601738 [No Abstract] [Full Text] [Related]
33. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative. Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567 [TBL] [Abstract][Full Text] [Related]
34. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623 [TBL] [Abstract][Full Text] [Related]
35. Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv. Paulish-Miller TE; Augostini P; Schuyler JA; Smith WL; Mordechai E; Adelson ME; Gygax SE; Secor WE; Hilbert DW Antimicrob Agents Chemother; 2014 May; 58(5):2938-43. PubMed ID: 24550324 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiprotozoal activity of mono- and bis-uracil isatin conjugates against the human pathogen Trichomonas vaginalis. Kumar K; Liu N; Yang D; Na D; Thompson J; Wrischnik LA; Land KM; Kumar V Bioorg Med Chem; 2015 Aug; 23(16):5190-7. PubMed ID: 25999204 [TBL] [Abstract][Full Text] [Related]